64 Stocks Moving In Tuesday's Mid-Day Session

Gainers
 

• Bridgeline Digital Inc BLIN shares climbed 32.8 percent to $8.20 after the company announced a multi-year license renewal agreement with a global biopharmaceutical company to power its mission-critical websites.
• Cohu, Inc. COHU rose 24.3 percent to $19.23 after reporting Q1 results.
• SolarEdge Technologies, Inc. SEDG rose 18.6 percent to $52.05 after the company reported higher-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance.
• ARCA biopharma, Inc. ABIO shares gained 18.5 percent to $13.48.
• Itron, Inc. ITRI climbed 17.5 percent to $62.83 after the company reported better-than-expected Q1 EPS and sales. Baird also upgraded the stock from Neutral to Outperform.
• Akoustis Technologies Inc. AKTS shares gained 13.9 percent to $7.29 after the company announced its first pre-production order for its 5.6 GHZ XBAW WiFi RF filter.
• Ducommun Incorporated DCO gained 13.2 percent to $48.26 after the company reported better-than-expected Q1 results.
• EverQuote, Inc. EVER rose 13.3 percent to $10.44 after the company reported Q1 EPS and sales up from last year.
• Ritter Pharmaceuticals Inc RTTR gained 12.7 percent to $0.98 after the company completed dosing of last patient in pivotal Phase 3 clinical trial of RP-G28 for the potential treatment of Lactose Intolerance.
• Servicemaster Global Holdings Inc SERV rose 12.5 percent to $55.53 after the company reported better-than-expected Q1 EPS and sales, and issued FY19 sales guidance in line with estimates.
• Akorn, Inc. AKRX rose 11.6 percent to $3.38 after the company reported upbeat Q1 results and issued strong FY19 sales outlook.
• Cray Inc. CRAY gained 11.4 percent to $29.22.
• Veeco Instruments Inc. VECO gained 10.6 percent to $14.34 after reporting upbeat Q1 results.
• Central Garden & Pet Company CENTA rose 10.5 percent to $26.29 following Q2 earnings.
• Vivint Solar, Inc. VSLR rose 8.7 percent to $6.72.
• Moleculin Biotech Inc MBRX climbed 8.6 percent to $1.43 after the company announced additional positive interim results in first cohort of Phase 1/2 clinical studies of Annamycin in acute myeloid leukemia in Europe.
• Beyond Meat, Inc. BYND gained 8.6 percent to $81.25.
• Planet Green Holdings Corp. PLAG shares rose 8.3 percent to $4.55.
• Avid Technology, Inc. AVID surged 8 percent to $10.04 after the company reported better-than-expected Q1 EPS and sales.
• Carolina Trust BancShares, Inc. CART shares rose 8 percent to $8.85.
• TopBuild Corp BLD gained 7.4 percent to $79.35 after the company reported better-than-expected Q1 EPS and sales, and issued strong FY19 sales guidance.
• Adient plc ADNT shares fell 7 percent to $22.64 after reporting Q2 results.
• American International Group, Inc. AIG rose 6.3 percent to $50.05 after the company reported stronger-than-expected earnings for its first quarter.
• Clarus Corp CLAR rose 6.2 percent to $14.46 after reporting a first-quarter earnings beat.
• Israel Chemicals Ltd. ICL shares rose 5.5 percent to $5.39 after reporting Q1 earnings.
• GW Pharmaceuticals plc GWPH shares rose 5.3 percent to $189.56 after the company reported positive results from an Epidiolex trial.
• Auris Medical Holding Ltd EARS gained 5.3 percent to $5.31 after the company reached the midpoint for enrollment in its Phase 1b proof-of-concept trial of AM-201, the company's investigational drug for the prevention of antipsychotic-induced weight gain and somnolen.
• Dean Foods Co DF gained 4.8 percent to $1.76 after the company issued a Q1 miss but upbeat FY19 guidance.
• Ferrari N.V. RACE rose 4.2 percent to $137.71 after the company reported better-than-expected Q1 financial results.
• US Foods Holding Corp USFD rose 3.9 percent to $38.19 after the company announced better-than-expected results for its first quarter.
• Crocs, Inc. CROX gained 3.1 percent to $29.22 after the company reported better-than-expected Q1 EPS and sales.

Check out these big penny stock gainers and losers

Losers

• Catalyst Pharmaceuticals, Inc. CPRX dipped 40.4 percent to $3.6400 after the FDA approved the company's competitor to its Firdapse drug.
• Intersect ENT, Inc. XENT fell 21.5 percent to $26.03 after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered the price target from $41 to $29 following the company report of worse-than-expected Q1 EPS. The company also cut FY19 sales guidance.
• Nautilus, Inc. NLS tumbled 17.8 percent to $4.34 after the company reported worse-than-expected Q1 EPS and sales results.
• Mylan NV MYL dipped 17.3 percent to $23.38 after the company reported mixed Q1 EPS and sales results.
• Glu Mobile Inc. GLUU dropped 17 percent to $ 9.31 after reporting a first-quarter earnings miss.
• Lannett Company, Inc. LCI shares dipped 15.6 percent to $7.66 following Q3 results.
• Ovid Therapeutics Inc. OVID fell 15.4 percent to $1.8101 following weak quarterly earnings.
• Tuesday Morning Corporation TUES fell 14.1 percent to $1.83 after the company reported Q3 results and raised its FY19 loss guidance.
• Industrea Acquisition Corp. BBCP dipped 13.8 percent to $5.61 after reporting a 15 million share common stock offering.
• Phibro Animal Health Corporation PAHC dropped 13.1 percent to $ 32.02 after the company reported worse-than-expected Q3 financial results and lowered its 2019 EPS expectations.
• Kornit Digital Ltd. KRNT dipped 13.1 percent to $24.47 after Spruce Point Capital published a 'Strong Sell' report on the stock.
• TherapeuticsMD Inc TXMD shares fell 12.3 percent to $3.99 after the company reported worse-than-expected Q1 sales results.
• HighPoint Resources Corporation HPR dropped 12.3 percent to $2.3150 following Q1 results.
• IAMGOLD Corporation IAG fell 12.2 percent to $2.5550 following Q1 earnings.
• Greenlight Capital Re, Ltd. GLRE dropped 12.1 percent to $10.86 following Q1 results.
• Viomi Technology Co., Ltd VIOT tumbled 11.7percent to $10.30.
• Navios Maritime Holdings Inc. NM dropped 11.6 percent to $4.1301.
• Sterling Construction Company, Inc. STRL fell 11.2 percent to $12.29 after reporting weak Q1 results.
• Invacare Corporation IVC dropped 11.1 percent to $6.91 after the company reported a worse-than-expected Q1 EPS and sales. The company also reaffirmed their FY19 guidance.
• Mueller Water Products, Inc. MWA tumbled 10.6 percent to $9.57 after reporting downbeat Q2 results.
• Health Insurance Innovations, Inc. HIIQ dropped 10.6 percent to $23.11 after the company reported lower-than-expected Q1 EPS and sales results.
• AMAG Pharmaceuticals, Inc. AMAG fell 10.2 percent to $10.68 following weak quarterly results.
• LGI Homes, Inc. LGIH fell 9.8 percent to $63.96 following downbeat Q1 results.
• Insmed Incorporated INSM fell 9.5 percent to $29.12 after the company reported mixed Q1 financial results.
• Del Frisco's Restaurant Group, Inc. DFRG dropped 9.2 percent to $6.02 following weak quarterly sales.
• Adient plc ADNT fell 9.1 percent to $22.14 after the company reported worse-than-expected Q2 EPS and sales results.
• Aramark ARMK fell 8.6 percent to $28.61 after the company reported worse-than-expected Q2 EPS and sales, and issued weak FY19 EPS guidance.
• Fred's, Inc. FRED dipped 7.2 percent to $0.5939 after the company reported a worse-than-expected Q4 EPS results.
• Novanta Inc. NOVT dropped 7 percent to $81.35 after the company issued worse-than-expected Q2 EPS guidance.
• Vericel Corporation VCEL fell 4.6 percent to $17.55 after reporting weak Q1 results.
• Denbury Resources Inc. DNR fell 4.4 percent to $1.97 after the company reported worse-than-expected Q1 sales results.
• Expeditors International of Washington EXPD dropped 4.2 percent to $75.44 after the company reported mixed Q1 results, with a EPS miss and a sales beat.
• MannKind Corporation MNKD dropped 4 percent to $1.49 after the company reported a $50 million common stock offering. The company also reported better-than-expected Q1 results.